Adimmune Corporation operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Adimmune with three other
companies in this sector in Taiwan:
sales of 678.66 million Taiwanese Dollars [US$22.29 million]
Genmont Biotech Inc
(540.78 million Taiwanese Dollars [US$17.76 million]
of which 64%
was Jingyue Company), and
Syn-Tech Chem. & Pharm. Co., Ltd.
(766.79 million Taiwanese Dollars [US$25.18 million]
of which 100%
was Mfg of Medicine).
Adimmune reported sales of 606.73 million Taiwanese Dollars (US$19.92 million)
December of 2016.
increase of 108.7%
versus 2015, when the company's sales were 290.74 million Taiwanese Dollars.